Decision of the EEA Joint Committee No 305/2023 of 8 December 2023 amending Annex... (22024D1374)
EU - Internationale Abkommen
2024/1374
13.6.2024

DECISION OF THE EEA JOINT COMMITTEE No 305/2023

of 8 December 2023

amending Annex I (Veterinary and phytosanitary matters) and Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1374]

THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
(1) Commission Implementing Regulation (EU) 2022/1646 of 23 September 2022 on uniform practical arrangements for the performance of official controls as regards the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof, on specific content of multi-annual national control plans and specific arrangements for their preparation  ( 1 ) is to be incorporated into the EEA Agreement.
(2) Implementing Regulation (EU) 2022/1646 repeals Commission Decision 97/747/EC  ( 2 ) , which is incorporated into the EEA Agreement, and which is consequently to be repealed under the EEA Agreement.
(3) This Decision concerns legislation regarding veterinary matters, feedingstuffs and foodstuffs. Legislation regarding veterinary matters, feedingstuffs and foodstuffs shall not apply to Liechtenstein as long as the application of the Agreement between the European Community and the Swiss Confederation on trade in agricultural products is extended to Liechtenstein, as specified in the sectoral adaptations to Annex I and the introduction to Chapter XII of Annex II to the EEA Agreement. This Decision is therefore not to apply to Liechtenstein.
(4) Annexes I and II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:

Article 1

Annex I to the EEA Agreement shall be amended as follows:
1.
The following is inserted after point 11h (Commission Delegated Regulation (EU) 2022/1644) in Part 1.1 of Chapter I:
‘11i.
32022 R 1646 : Commission Implementing Regulation (EU) 2022/1646 of 23 September 2022 on uniform practical arrangements for the performance of official controls as regards the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof, on specific content of multi-annual national control plans and specific arrangements for their preparation ( OJ L 248, 26.9.2022, p. 32 ).
The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following adaptation:
The following is added to the table in Annex II:
 

Iceland

10

Norway

95

” ’
2.
The following is inserted after point 31w (Commission Delegated Regulation (EU) 2022/1644) of Chapter II:
‘31x.
32022 R 1646 : Commission Implementing Regulation (EU) 2022/1646 of 23 September 2022 on uniform practical arrangements for the performance of official controls as regards the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof, on specific content of multi-annual national control plans and specific arrangements for their preparation ( OJ L 248, 26.9.2022, p. 32 ).
The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following adaptation:
The following is added to the table in Annex II:
 

Iceland

10

Norway

95

” ’
3.
The text of point 13 (Commission Decision 97/747/EC) in part 7.2 is deleted.

Article 2

The following is inserted after point 164ze (Commission Delegated Regulation (EU) 2022/1644) of Chapter XII of Annex II to the EEA Agreement:
‘164zf.
32022 R 1646 : Commission Implementing Regulation (EU) 2022/1646 of 23 September 2022 on uniform practical arrangements for the performance of official controls as regards the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof, on specific content of multi-annual national control plans and specific arrangements for their preparation ( OJ L 248, 26.9.2022, p. 32 ).
The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following adaptation:
The following is added to the table in Annex II:
 

Iceland

10

Norway

95

” ’

Article 3

The text of Implementing Regulation (EU) 2022/1646 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 4

This Decision shall enter into force on 9 December 2023, provided that all the notifications under Article 103(1) of the EEA Agreement have been made  ( *1 ) .

Article 5

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .
Done at Brussels, 8 December 2023.
For the EEA Joint Committee
The President
Pascal SCHAFHAUSER
( 1 )    OJ L 248, 26.9.2022, p. 32 .
( 2 )    OJ L 303, 6.11.1997, p. 12 .
( *1 )   No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2024/1374/oj
ISSN 1977-0677 (electronic edition)
Markierungen
Leseansicht